Protein Expression Market 2024 - Industry Size, Future Insights, Growth Drivers And Top Players

The Business Research Company recently released a comprehensive report on the Global Protein Expression Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.

Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=2493&type=smp

According to The Business Research Company's, The protein expression market size has grown rapidly in recent years. It will grow from $3.19 billion in 2023 to $3.56 billion in 2024 at a compound annual growth rate (CAGR) of 11.5%. The growth in the historic period can be attributed to scientific research, biopharmaceutical development, biotechnology advancements, drug discovery and development, healthcare industry growth.

The protein expression market size is expected to see rapid growth in the next few years. It will grow to $5.7 billion in 2028 at a compound annual growth rate (CAGR) of 12.5%. The growth in the forecast period can be attributed to personalized medicine, biosimilars market, drug repurposing, regulatory support, precision agriculture. Major trends in the forecast period include cell-free expression systems, crispr-cas9 for gene editing, sustainable bioprocessing, contract research and manufacturing, multi-modal expression platforms.

Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/protein-expression-global-market-report

Market Drivers and Trends:

An increase in demand for biologics to counter various genetic disorders and chronic diseases is one the major factors driving the research and sales of protein expression market. Biologics is a medicine produced from living organisms or contains components of living organisms such as protein, tissue, genes, allergens, cells, blood components, blood, and vaccines. The increasing use of biologics (therapeutic protein and others) to cure chronic diseases such as cancer, cardiovascular conditions and genetic disorders, is increasing the demand for protein expression devices and equipment. For instance, in September 2022, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations, there were 41 million deaths, which is 74% of those caused by non-communicable diseases (NCDs) or chronic diseases every year globally. Hence the rising demand for biologics is driving the protein expression market. For instance, according to an article published by Chemistry World, analysts stated that the biologics market hold a market share of more than a quarter of the entire pharmaceutical market in 2020. The global biologics market is expected to grow at 14.7% during 2021-2023.

Major companies operating in the protein expression market are increasing their focus on introducing next-generation solutions, such as Visium CytAssist Gene and Protein Expression Assay, to maximize their revenues in the market. Next-generation solutions refer to the use of advanced technologies and techniques to improve the efficiency, accuracy, and speed of protein expression. For instance, in May 2023, 10x Genomics Inc., a US-based biotechnology company, launched the Visium CytAssist Gene and Protein Expression Assay to allow researchers to study the relative expression patterns of proteins within the human immune system. With Visium's unique morphology-first approach, H&E (Hematoxylin and Eosin) staining can be done before any chemical treatments are applied to the tissue section. This enables three-dimensional spatial analysis on the exact same sample while allowing researchers to investigate the morphology of their tissue on the same slice they use for deeper spatial multiomic inquiry. Utilizing a sequencing-based readout, Visium CytAssist Gene and Protein Expression enables the simultaneous collection of protein and entire transcriptome gene expression with histological analysis in a single experiment from a single tissue section.

Key Benefits for Stakeholders:

• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.

Major Key Players of the Market:

Agilent Technologies Inc., Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., New England Biolabs Inc., Promega Corporation, Qiagen NV, Takara Bio Inc., Merck KGaA, Genscript Biotech Corporation, Life Technologies Corporation, Sigma-Aldrich Corporation, Lucigen Corporation, Synthetic Genomics Inc., Becton, Dickinson & Company, Lonza Group Ltd., Geneva Biotech LLC, Viva Biotech Holdings, Sengenics LLC, ARTES Biotechnology GmbH, Addgene Inc., Profacgen, ProteoGenix Inc., Peak Proteins Ltd., Domainex Ltd., Jena Bioscience GmbH, EMD Millipore Corporation, Oxford Expression Technologies Ltd., Creative Biolabs Inc., Abnova Taiwan Corp, Accelagen Inc.

Protein Expression Market 2024 Key Insights:

• The protein expression market size is expected to see rapid growth in the next few years. It will grow to $5.7 billion in 2028 at a compound annual growth rate (CAGR) of 12.5%.
• Growing Demand For Biologics Boosts The Protein Expression Market
• Next-Generation Protein Expression Solutions In The Market
• North America was the largest region in the protein expression market in 2023

We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/Customise?id=2493&type=smp

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.